# Scopus BioPharma Inc.

Scopus BioPharma Inc. is a company headquartered in New York, NY, United States.

## Company overview

- **Legal name:** Scopus BioPharma Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** New York, NY, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001772028

## About

Scopus BioPharma Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001772028, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-04-14, it reported annual revenue of USD 0; net income of USD -11,609,827; total assets of USD 392,265 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$11.6M (USD -11,609,827)
- **Total assets:** $392,265 (USD 392,265)
- **Cash and equivalents:** $124,575 (USD 124,575)
- **Operating cash flow:** -$8.1M (USD -8,126,628)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$27.0M (USD -26,953,409)
- **Total assets:** $8.2M (USD 8,187,715)
- **Cash and equivalents:** $7.9M (USD 7,942,971)
- **Operating cash flow:** -$11.4M (USD -11,424,637)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$10.9M (USD -10,862,292)
- **Total assets:** $2.0M (USD 1,974,068)
- **Cash and equivalents:** $1.8M (USD 1,832,100)
- **Operating cash flow:** -$2.5M (USD -2,525,289)

## Recent SEC filings

- Form 8-K — filed 2023-08-18 — period 2023-08-14 — FORM 8-K
- Form 8-K — filed 2023-08-11 — period 2023-08-10 — FORM 8-K
- Form 10-Q — filed 2023-08-11 — period 2023-06-30 — 10-Q
- Form DEF 14A — filed 2023-07-21 — period 2023-07-21 — DEF 14A
- Form 10-Q — filed 2023-05-12 — period 2023-03-31 — 10-Q
- Form 10-K/A — filed 2023-04-28 — period 2022-12-31 — 10-K/A
- Form 10-K — filed 2023-04-14 — period 2022-12-31 — 10-K
- Form 8-K — filed 2022-12-16 — period 2022-12-15 — FORM 8-K
- Form 8-K — filed 2022-12-02 — period 2022-12-01 — FORM 8-K
- Form 10-Q — filed 2022-11-21 — period 2022-09-30 — 10-Q
- Form 8-K — filed 2022-10-20 — period 2022-10-14 — FORM 8-K
- Form 8-K — filed 2022-10-19 — period 2022-10-18 — FORM 8-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/scopus-biopharma-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology